Wikidata

(Q63828962)

English

Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in Previously Treated Subjects With Severe Hemophilia A

clinical trial

In more languages

Statements

title
A-LONG: An Open-Label, Multicenter Evaluation of the Safety, Pharmacokinetics, and Efficacy of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in the Prevention and Treatment of Bleeding in Previously Treated Subjects With Severe Hemophilia A (English)
0 references
country
Australia
0 references
Austria
0 references
Belgium
0 references
Brazil
0 references
Canada
0 references
France
0 references
Germany
0 references
India
0 references
Israel
0 references
Italy
0 references
Japan
0 references
New Zealand
0 references
South Africa
0 references
Spain
0 references
Sweden
0 references
Switzerland
0 references
United Kingdom
0 references
start time
November 2010
0 references
end time
August 2012
0 references
number of participants
165
0 references
minimum age
12 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63828962&oldid=1857427169"